Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 2 June 2006. doi:10.1136/jcp.2005.034942
Journal of Clinical Pathology 2006;59:978-983
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

ORIGINAL ARTICLE

Cytogenetic analysis of myxoid liposarcoma and myxofibrosarcoma by array-based comparative genomic hybridisation

T Ohguri1, M Hisaoka1, S Kawauchi2, K Sasaki2, T Aoki3, S Kanemitsu1, A Matsuyama1, Y Korogi3 and H Hashimoto1

1 Department of Pathology and Oncology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
2 Department of Pathology, Yamaguchi University School of Medicine, Yamaguchi, Japan
3 Department of Radiology, School of Medicine, University of Occupational and Environmental Health

Correspondence to:
Correspondence to:
H Hashimoto
Department of Pathology and Oncology, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555,Japan;hiroshi{at}med.uoeh-u.ac.jp

Aim: To investigate overall chromosomal alterations using array-based comparative genomic hybridisation (CGH) of myxoid liposarcomas (MLSs) and myxofibrosarcomas (MFSs).

Materials and methods: Genomic DNA extracted from fresh-frozen tumour tissues was labelled with fluorochromes and then hybridised on to an array consisting of 1440 bacterial artificial chromosome clones representing regions throughout the entire human genome important in cytogenetics and oncology.

Results: DNA copy number aberrations (CNAs) were found in all the 8 MFSs, but no alterations were found in 7 (70%) of 10 MLSs. In MFSs, the most frequent CNAs were gains at 7p21.1–p22.1 and 12q15–q21.1 and a loss at 13q14.3–q34. The second most frequent CNAs were gains at 7q33–q35, 9q22.31–q22.33, 12p13.32–pter, 17q22–q23, Xp11.2 and Xq12 and losses at 10p13–p14, 10q25, 11p11–p14, 11q23.3–q25, 20p11–p12 and 21q22.13–q22.2, which were detected in 38% of the MFSs examined. In MLSs, only a few CNAs were found in two sarcomas with gains at 8p21.2–p23.3, 8q11.22–q12.2 and 8q23.1–q24.3, and in one with gains at 5p13.2–p14.3 and 5q11.2–5q35.2 and a loss at 21q22.2–qter.

Conclusions: MFS has more frequent and diverse CNAs than MLS, which reinforces the hypothesis that MFS is genetically different from MLS. Out-array CGH analysis may also provide several entry points for the identification of candidate genes associated with oncogenesis and progression in MFS.

Abbreviations: CGH, comparative genomic hybridisation; CNAs, copy number aberrations; MDM2, murine double minutes 2; MFH, malignant fibrous histiocytoma; MFS, myofibrosarcoma; MLS, myxoid liposarcoma


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs